BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22430378)

  • 1. Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes.
    Sinenko SA; Ponomartsev SV; Tomilin AN
    Cell Mol Life Sci; 2021 Feb; 78(4):1207-1220. PubMed ID: 33011821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Base editing: a novel cure for severe combined immunodeficiency.
    Ha TC; Morgan M; Schambach A
    Signal Transduct Target Ther; 2023 Sep; 8(1):354. PubMed ID: 37718346
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy helps children with immunodeficiency.
    O'Leary K
    Nat Med; 2021 Jun; ():. PubMed ID: 34113012
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel gene therapy advances for treating primary immunodeficiency disorders - an update.
    Amin R; Darwin R; Chakraborty S; Dey BK; Dhama K; Emran TB
    Ann Med Surg (Lond); 2023 Dec; 85(12):5859-5862. PubMed ID: 38098588
    [No Abstract]   [Full Text] [Related]  

  • 5. Generation and Hematopoietic Differentiation of Mesenchymal Stromal/Stem Cell-Derived Induced Pluripotent Stem Cell Lines for Disease Modeling of Hematopoietic and Immunological Diseases.
    Güney-Esken G; Aerts-Kaya F
    Methods Mol Biol; 2022; 2549():23-42. PubMed ID: 34907509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary immunodeficiency modeling with induced pluripotent stem cells.
    Pessach IM; Notarangelo LD
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):505-11. PubMed ID: 22001741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    Liras A
    Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
    Mikkers H; Pike-Overzet K; Staal FJ
    Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.